Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-15

Clinical Trial Update: Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)? [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether Welchol (colesevelam) improves colonic transit in diarrhea-predominant irritable bowel syndrome; results were posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Welchol (colesevelam hydrochloride)

Snippet

Sponsor: Mayo Clinic | Conditions: Irritable Bowel Syndrome, Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2012-03-15